The application of EPSiT in pilonidal sinus disease: an international Delphi consensus study endorsed by the Association of Laparoscopic Surgeons of Great Britain and Ireland (ALSGBI) - Scorecard - MDSpire
Advertisement
The application of EPSiT in pilonidal sinus disease: an international Delphi consensus study endorsed by the Association of Laparoscopic Surgeons of Great Britain and Ireland (ALSGBI)
Clinical Scorecard: Utilization of EPSiT for Pilonidal Sinus Disease: An International Delphi Consensus Study Supported by the Association of Laparoscopic Surgeons of Great Britain and Ireland (ALSGBI)
At a Glance
Category
Detail
Condition
Chronic pilonidal sinus disease (PD)
Key Mechanisms
Minimally invasive endoscopic treatment involving diagnostic and therapeutic phases using fistuloscope to remove hairs, cauterise fistula tracts, and remove epithelial/granulation tissue under direct vision
Target Population
Adults and children with primary or recurrent pilonidal sinus disease
Care Setting
Surgical setting with prone patient positioning, single-dose antibiotic prophylaxis, and post-operative outpatient wound care
Key Highlights
EPSiT and VAAPS are minimally invasive alternatives to traditional surgery with reduced complications, pain, hospital stay, and faster recovery.
Despite benefits, EPSiT uptake remains low in the UK due to evolving evidence, lack of guidelines, training gaps, and technique modifications.
Delphi consensus study aims to standardise EPSiT technique and improve adoption, endorsed by ALSGBI with expert international surgeon participation.
Guideline-Based Recommendations
Diagnosis
Perform diagnostic phase using fistuloscope to identify sinus cavity and fistula tracts under direct vision.
Management
Administer single-dose antibiotic prophylaxis pre-operatively.
Make a 5-mm incision around the discharging sinus for fistuloscope introduction.
Remove all hairs inside the sinus with forceps.
Cauterise fistula cavity and tracts with electrode.
Remove epithelial and granulation tissue with endobrush or Volkmann spoon.
Infuse glycine/mannitol 1% solution during EPSiT procedure.
Post-operative wound care with light dressing, no packing, and once-daily saline wound washing for at least 2 weeks.
Monitoring & Follow-up
Monitor for wound infection, wound dehiscence, seroma, and haematoma, noting reduced incidence compared to conventional surgery.
Assess for disease recurrence, acknowledging no significant difference in recurrence rates compared to traditional surgery.
Risks
Potential for disease recurrence similar to conventional surgery.
Possible complications include wound infection, wound breakdown, seroma, and haematoma, though rates are reduced.
Patient & Prescribing Data
Patients with limited or recurrent pilonidal sinus disease undergoing EPSiT.
EPSiT offers reduced post-operative pain, shorter hospital stay, and faster return to daily activities compared to conventional surgery, but recurrence risk remains similar.
Clinical Best Practices
Standardise EPSiT technique to improve uptake and outcomes.
Use prone positioning and single-dose antibiotic prophylaxis during procedure.
Employ direct vision endoscopic approach with appropriate irrigation solution (glycine/mannitol 1%).
Avoid wound packing post-operatively; use light dressing and daily saline irrigation.
Incorporate EPSiT training into surgical education to address current uptake barriers.
Consider EPSiT as treatment of choice for limited disease and apply same approach for recurrent disease.
by H. K. Sekhon Inderjit Singh, P. Meinero, F. C. Campanile, A. Quddus, R. Rajaganeshan, J. Warusavitarne, V. Dotlacil, A. Bhargava, P. Giordano, A. Pini Prato, V. Shatkar, P. Jalali, V. C. Halahakoon, G. Gallo, M. Milone, S. Mantoo, C. A. Leo, C. Esposito, M. Farghaly, T. Arulampalam, N. Pawa